Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +5.45% | +3.45% | +38.89% |
07/03 | Earnings Flash (IDXG) INTERPACE BIOSCIENCES Reports Q4 Revenue $10.3M | MT |
07/03 | Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 31.84M 2.65B | Sales 2023 | 40.21M 3.35B | Capitalization | 4.69M 391M |
---|---|---|---|---|---|
Net income 2022 | -22M -1.83B | Net income 2023 | - 0 | EV / Sales 2022 | 0.49 x |
Net Debt 2022 | 11.26M 939M | Net Debt 2023 | 7.69M 642M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
6.03
x | Employees | 108 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.42% |
1 day | +5.45% | ||
1 week | +3.45% | ||
1 month | -6.25% | ||
3 months | +42.86% | ||
6 months | +78.57% | ||
Current year | +38.89% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 62 | 01/20/01 |
Director of Finance/CFO | 32 | 01/19/01 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vijay Aggarwal
BRD | Director/Board Member | 75 | 01/22/01 |
Joseph Keegan
BRD | Director/Board Member | 71 | 01/16/01 |
Stephen Sullivan
BRD | Director/Board Member | 77 | 01/04/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.5 | +5.45% | 5,677 |
25/24/25 | 1.422 | -8.34% | 2,378 |
24/24/24 | 1.552 | +5.76% | 102 |
23/24/23 | 1.468 | +1.21% | 4,751 |
22/24/22 | 1.45 | 0.00% | 860 |
Delayed Quote OTC Markets, April 27, 2024 at 01:22 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+38.89% | 6.56M | |
-15.06% | 5.53B | |
+0.60% | 1.26B |
- Stock Market
- Equities
- IDXG Stock